JP2003522786A5 - - Google Patents

Download PDF

Info

Publication number
JP2003522786A5
JP2003522786A5 JP2001559447A JP2001559447A JP2003522786A5 JP 2003522786 A5 JP2003522786 A5 JP 2003522786A5 JP 2001559447 A JP2001559447 A JP 2001559447A JP 2001559447 A JP2001559447 A JP 2001559447A JP 2003522786 A5 JP2003522786 A5 JP 2003522786A5
Authority
JP
Japan
Prior art keywords
group
butyl
butyl group
metal
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001559447A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003522786A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/004897 external-priority patent/WO2001060349A2/en
Publication of JP2003522786A publication Critical patent/JP2003522786A/ja
Publication of JP2003522786A5 publication Critical patent/JP2003522786A5/ja
Pending legal-status Critical Current

Links

JP2001559447A 2000-02-15 2001-02-15 薬理学的薬剤、及び治療の方法 Pending JP2003522786A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18260800P 2000-02-15 2000-02-15
US60/182,608 2000-02-15
PCT/US2001/004897 WO2001060349A2 (en) 2000-02-15 2001-02-15 Pharmacological agent comprising picolinic acid, fusaric acid and derivatives thereof.

Publications (2)

Publication Number Publication Date
JP2003522786A JP2003522786A (ja) 2003-07-29
JP2003522786A5 true JP2003522786A5 (cg-RX-API-DMAC7.html) 2005-08-25

Family

ID=22669217

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001559447A Pending JP2003522786A (ja) 2000-02-15 2001-02-15 薬理学的薬剤、及び治療の方法

Country Status (10)

Country Link
US (1) US6403618B1 (cg-RX-API-DMAC7.html)
EP (1) EP1257262A2 (cg-RX-API-DMAC7.html)
JP (1) JP2003522786A (cg-RX-API-DMAC7.html)
AU (1) AU781066B2 (cg-RX-API-DMAC7.html)
BR (1) BR0108400A (cg-RX-API-DMAC7.html)
DE (1) DE01909253T1 (cg-RX-API-DMAC7.html)
ES (1) ES2215493T1 (cg-RX-API-DMAC7.html)
MX (1) MXPA02007954A (cg-RX-API-DMAC7.html)
TR (1) TR200301378T3 (cg-RX-API-DMAC7.html)
WO (1) WO2001060349A2 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060074063A1 (en) * 1995-12-29 2006-04-06 Fernandez-Pol Jose A Pharmacological agent and method of treatment
US6579891B1 (en) * 1995-12-29 2003-06-17 Novactyl, Inc. Agent and method for prevention and treatment of cancer in animals
CA2456269A1 (en) * 2001-08-23 2003-03-06 The Government Of The United States Of America Methods of inhibiting formation of vascular channels and profileration using pyridinone derivatives
AU2002367087A1 (en) * 2001-12-21 2003-07-15 7Tm Pharma A/S Method for the treatment of mc receptor related disorders with a chelate and/or a chelator
CN101134119A (zh) * 2002-05-24 2008-03-05 血管技术国际股份公司 用于涂覆医用植入物的组合物和方法
US8313760B2 (en) 2002-05-24 2012-11-20 Angiotech International Ag Compositions and methods for coating medical implants
US20050158356A1 (en) * 2003-11-20 2005-07-21 Angiotech International Ag Implantable sensors and implantable pumps and anti-scarring agents
CA2552607C (en) * 2004-01-07 2012-04-17 E-L Management Corporation Cosmetic composition and method for retarding hair growth
US20050239723A1 (en) * 2004-04-27 2005-10-27 Amin Avinash N Compositions and methods useful for treatment of acne
US20070178062A1 (en) * 2005-10-07 2007-08-02 Nathan Ravi Treatment of presbyopia with picolinic acid and its analogs
JP2009512454A (ja) * 2005-10-20 2009-03-26 ビアメト ファーマシューティカルズ,インク. 金属タンパク質のメタル化経路のモジュレーターのスクリーニング方法
EP2482807A4 (en) 2009-10-02 2013-04-24 Brigham & Womens Hospital COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS OF CONTACT DERMATITIS
GB201317619D0 (en) 2013-10-04 2013-11-20 Uni I Oslo Compounds
WO2018022823A1 (en) * 2016-07-28 2018-02-01 Asieris Pharmaceutical Technologies Co., Ltd. Uses of dopamine beta-hydroxylase (dbh) inhibitors and serotonin receptor (5-ht) antagonists for the treatment of cancer
GB201613946D0 (en) 2016-08-15 2016-09-28 Univ Oslo Compounds
WO2026104587A1 (en) 2024-11-13 2026-05-21 Adjutec Pharma As Cyclic boronic acid esters useful as adjuvants in the treatment of bacterial infections

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3903285A (en) 1972-12-29 1975-09-02 Microbial Chem Res Found Method for treating parkinsonism
CH629488A5 (en) 1975-11-28 1982-04-30 Scherico Ltd Processes for preparing novel picolinic acid derivatives.
ZA767103B (en) 1975-11-28 1977-10-26 Scherico Ltd Picolinic acid derivatives and processes for their preparation
US4044140A (en) 1975-11-28 1977-08-23 Schering Corporation Trityl picolinic acid derivatives and their use as anti-acne agents
US4120762A (en) 1977-09-30 1978-10-17 Alden Research Foundation Electrochemical recording medium
US4293547A (en) 1980-08-25 1981-10-06 The Upjohn Company Method of treating malaria
US4443459A (en) 1981-05-26 1984-04-17 Banyu Pharmaceutical Co., Ltd. α-Tocopheryl ester of 5-substituted picolinic acid and hypotensive composition containing it
US4814351A (en) 1987-06-26 1989-03-21 Redken Laboratories, Inc. Scalp treatment
US5536743A (en) 1988-01-15 1996-07-16 Curatek Pharmaceuticals Limited Partnership Intravaginal treatment of vaginal infections with buffered metronidazole compositions
US5057320A (en) 1988-08-01 1991-10-15 Nutrition 21 Means and method for increasing skin respiration
US5157046A (en) 1988-11-29 1992-10-20 Janssen Pharmaceutica N.V. Method of treating epithelial disorders
US5219847A (en) 1989-06-12 1993-06-15 Shiseido Company, Ltd. Antipruritic composition
FR2657259A1 (fr) 1990-01-25 1991-07-26 Adir Utilisation de la n-myristoyl-(s)-phenylalanine pour l'obtention de medicaments destines au traitement des maladies faisant intervenir la myristoylation.
US5484951A (en) 1990-10-19 1996-01-16 Octamer, Incorporated 5-iodo-6-amino-6-nitroso-1,2-benzopyrones useful as cytostatic and antiviral agents
US5391537A (en) 1990-10-25 1995-02-21 Kumiai Chemical Industry Co., Ltd. Picolinic acid derivative, and herbicidal composition
US5403816A (en) 1990-10-25 1995-04-04 Kumiai Chemical Industry Co., Ltd. Picolinic acid derivative and herbicidal composition
US5173486A (en) 1991-08-26 1992-12-22 Bristol-Myers Squibb Company Dibenz[b,f][1,4]oxazepin-11(10H)-ones for multidrug resistance reversing agents
US5516941A (en) 1991-10-22 1996-05-14 Octamer, Inc. Specific inactivators of "retroviral" (asymmetric) zinc fingers
IL104323A0 (en) 1992-01-10 1993-05-13 Smithkline Beecham Corp Hemoregulatory peptides
US5284840A (en) 1992-06-12 1994-02-08 Merck & Co., Inc. Alkylidene macrolides having immunosuppressive activity
US5962463A (en) * 1992-10-09 1999-10-05 Massachusetts Institute Of Technology Methods of stimulating non-amyloidogenic processing of the amyloid precursor protein
AU7044994A (en) 1993-05-24 1994-12-20 Nycomed Pharma Hemoregulatory peptides
US6001555A (en) 1994-09-23 1999-12-14 The United States Of America As Represented By The Department Of Health And Human Services Method for identifying and using compounds that inactivate HIV-1 and other retroviruses by attacking highly conserved zinc fingers in the viral nucleocapsid protein
FR2736263B1 (fr) 1995-07-07 1997-09-26 C3D Sarl Composition dermocosmetique depigmentante et son utilisation
US5767135A (en) 1995-12-29 1998-06-16 Fernandez-Pol; Jose Alberto Antiviral agent
JP3337992B2 (ja) 1997-11-04 2002-10-28 ファイザー製薬株式会社 5−置換ピコリン酸化合物及びその製造方法

Similar Documents

Publication Publication Date Title
JP5389668B2 (ja) 皮膚浸透率の非常に高い1H−イミダゾ[4,5−c]キノリン−4−アミン及び関連化合物の正に荷電した水溶性プロドラッグ
KR100211479B1 (ko) 3-[2-(디메틸아미노)에틸]-n-메틸-1h-인돌-5-메탄술폰아미드의 비강 투여 제제
JP2003507438A5 (cg-RX-API-DMAC7.html)
JP2007523842A (ja) 酸安定化されたインスリンを含有する薬学的製剤
JP2002511385A5 (cg-RX-API-DMAC7.html)
CN105143174A (zh) 治疗帕金森疾病的新型高穿透力药物和医药组合物
Nagai et al. Bioadhesive dosage forms for nasal administration
ES2215493T1 (es) Agente farmacologico que comprende acido picolinico, acido fusarico y sus derivados.
JP2021534099A5 (cg-RX-API-DMAC7.html)
JP2002528502A5 (cg-RX-API-DMAC7.html)
US20090123563A1 (en) Pharmaceutical Preparations Comprising Insulin, Zinc Ions and Zinc-Binding Ligand
JP2024504225A5 (cg-RX-API-DMAC7.html)
JP2010517987A (ja) 塩基性ペプチド及びその複合型抗細菌−抗真菌剤としての使用
JP2023503380A5 (cg-RX-API-DMAC7.html)
CA2587792A1 (en) Therapeutic compositions for intranasal administration of ketorolac
JP2006527185A5 (cg-RX-API-DMAC7.html)
EP0667163B1 (en) Powder for nasal administration of peptidic or proteinaceous drug
JPH03287535A (ja) プラノプロフェン水溶液
JP2008505866A (ja) インスリンを含有する薬学的製剤
US20050100563A1 (en) Antifungal compositions and methods of treatment therewith
ZA200507007B (en) Pharmaceutical preparations comprising acid-stabilised insulin
Nolting Open Studies of Ciclopirox Nail Lacquer in Onychomycosis—A Review
WO2001091782A1 (fr) Preparations de gouttes nasales contenant de la pralmoreline
AU3730201A (en) Use of particular compounds for prophylaxis and treatment of hepatitis
US20030153594A1 (en) Use of particular compounds for prophylaxis and treatment of hepatitis c